Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05023135 · ClinicalTrials.gov registry record
DeepView SnapShot Portable (DV-SSP): Device Training Study
A clinical trial of Burns and Wound Heal, sponsored by SpectralMD.
- Completed
- Registry status
- 251
- Enrollment target
- 11
- Study locations
NCT05023135: Completed study of Burns and Wound Heal, sponsored by SpectralMD.
NCT05023135 is a study of Burns and Wound Heal that has completed, run by SpectralMD. The registered enrollment target is 251 participants, above the 76-participant average among 36 other Burns trials with a reported enrollment target (230% higher). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05023135, a study of Burns and Wound Heal, has completed, sponsored by SpectralMD.
- COMPLETED
- Registry status
- 251 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.
Primary Outcome
Test that the Burn Segmentation Algorithm's predicted severe burn area (i.e., deep second degree and third degree) within an image of a burn injury, will be equivalent to the true area of severe burn as determined by the expert panel. The analysis for this study would only include data obtained from participants in the study.
Conditions Studied
Interventions
- DEVICE DeepView SnapShot Portable (DV-SSP)
Study Locations (11)
Louisiana
- University Medical Center New Orleans - New Orleans
- Children's Hospital - New Orleans
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Valleywise Health - Phoenix
Connecticut
- Bridgeport Hospital - Bridgeport
District of Columbia
- MedStar Health Research Institute - Washington D.C.
Massachusetts
- Massachusetts General Hospital - Boston
New York
- Stony Brook Medicine - Stony Brook
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2021-09-07 |
| Est. Completion | 2023-04-30 |
What the finished NCT05023135 record still lists
NCT05023135 is an observational study that tracks outcomes without assigning an intervention. The registered 251 participants enrollment target is mid-sized for trials with a published cap, above the 76-participant average among 36 other Burns trials with a reported enrollment target (230% higher).
The record links to 2 conditions, with Burns appearing as the primary indexed condition, and to 1 intervention - of which DeepView SnapShot Portable (DV-SSP) is the first listed.
NCT05023135 lists 11 locations in 10 states (Louisiana, Alabama, Arizona).
Frequently Asked Questions
What is clinical trial NCT05023135 about?
NCT05023135 is a clinical study titled "DeepView SnapShot Portable (DV-SSP): Device Training Study". The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.
What is the current status of trial NCT05023135?
This trial is currently completed. The enrollment target is 251 participants. The study started on 2021-09-07. Estimated completion is 2023-04-30.
What conditions does trial NCT05023135 study?
This clinical trial studies the following conditions: Burns, Wound Heal.
What interventions are being tested in trial NCT05023135?
The interventions under investigation include: DeepView SnapShot Portable (DV-SSP) (DEVICE).
Who is sponsoring clinical trial NCT05023135?
This trial is sponsored by SpectralMD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05023135 being conducted?
This trial has 11 study locations across Alabama, Arizona, Connecticut, District of Columbia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05023135's enrollment target sits among peer trials
251 4th of 36 higher than 33 of 36 other Burns trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Burns trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
RECRUITING · Phase 4
-
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
RECRUITING · Phase 4
-
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
RECRUITING · Phase 2
-
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06043817 · 251 participants · Phase 1
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI